The EPS growth outshines the yearly share price gain of 11%, indicating market caution towards the stock. Despite lower returns in the past year, the five-year returns of 13% per year suggest a positive market reception over time.
Amdocs' high P/E ratio is justified by its above-average forecasted growth. Shareholders' reluctance to sell indicates confidence in the company's prosperous future, suggesting the share price won't fall significantly soon.
With growing earnings per share and a conservative payout ratio, Amdocs illustrates a positive dividend outlook. The consistent dividend growth over the past decade indicates sustainability.
Amdocs Stock Forum
• $Express (EXPR.US)$ +10.92% (reporting quarterly results that were better than expected)
• $Caleres (CAL.US)$ +8.46% (In reaction to earnings)
• $21Vianet (VNET.US)$ +9% (In reaction to earnings)
• $The Wendy's Co (WEN.US)$ +8.9% (Trian Fund to explore and evaluate potential transactions; WEN Comments on Amended 13D Filing from Trian Partners)
• $Dycom Industries (DY.US)$ +7.2% (In reaction to earnings)
• $Photronics (PLAB.US)$ +...
No comment yet